- BNF:
- 4.7.2
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- None
Comments
brands include Targinact, Myloxifin (updated October 2023)
Do Not Prescribe (DNP) Drug Classifications
- 1: Are classified by the BNF as 'less suitable for prescribing', and includes anti-malarials (where a private prescription may be provided). Have a lack of data on effectiveness compared with standard therapy
- 2: Have a lack of data on safety compared with standard therapy
- 4: Have a lack of data on cost-effectiveness compared with standard therapy
search again